Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines

Nanoparticles are heterologous small composites that are usually between 1 and 100 nanometers in size. They are applied in many areas of medicine with one of them being drug delivery. Nanoparticles have a number of advantages as drug carriers which include reduced toxic effects, increased bioavailab...

Descripción completa

Detalles Bibliográficos
Autores principales: Namiot, Eugenia D., Sokolov, Aleksandr V., Chubarev, Vladimir N., Tarasov, Vadim V., Schiöth, Helgi B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821409/
https://www.ncbi.nlm.nih.gov/pubmed/36614230
http://dx.doi.org/10.3390/ijms24010787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821409/
https://www.ncbi.nlm.nih.gov/pubmed/36614230
http://dx.doi.org/10.3390/ijms24010787

Ejemplares similares